Dec 27 2024 10 mins 30
In this episode, we explore the use of high-dose olanzapine as a potential alternative to clozapine for treatment-resistant schizophrenia. We discuss a systematic review that examines the efficacy and safety of olanzapine doses above the FDA-approved maximum. Could high-dose olanzapine be a viable option when patients refuse clozapine?
Faculty: Oliver Freudenreich, M.D.
Host: Richard Seeber, M.D.
